Investors renew interest in biotech amid sluggish economy

11/14/2012 | Nature

A dozen biotech firms have floated initial public offerings so far this year, and the stocks have outperformed the Nasdaq Composite Index since the first quarter of 2011. IPOs can help young companies survive and expand research capacity, and rising confidence can attract money from investors who do not specialize in health care. An overall sluggish economy might be helping the biotech sector, where "earnings tend to grow independently of the economy, unlike electronics or consumer products," said Eric Schmidt, an analyst at investment bank Cowen and Company.

View Full Article in:

Nature

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN